 AUSTIN, Texas, Aug. 31, 2022 GLOBE NEWSWIRE -- Molecular Templates, Inc., Nasdaq: MTEM, Molecular Templates or MTEM a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies ETBs, will participate in the following September 2022 conferences. Presentation links can be found in the News and Media section of the corporate website. One-on-one meetings may be scheduled via conference representatives or directly with Molecular Templates. 